Ontology of Adverse Events
Names
More detailed information about this field from each metasource.
Ontology of Adverse Events
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
OAE
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
Names
More detailed information about this field from each metasource.
Ontology of Adverse Events
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
OAE
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
Names
More detailed information about this field from each metasource.
Ontology of Adverse Events
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
OAE
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
The Ontology of Adverse Events (OAE) is a community-driven ontology that is developed to standardize and integrate data on biomedical adverse events (e.g., vaccine and drug adverse events) and support computer-assisted reasoning. As a result of a medical intervention, events may occur which lie outside the intended consequences of the intervention. Some of these events are adverse events, in the sense that they are pathological bodily processes. For many such adverse events it is unclear whether they are causal consequences of the medical intervention which preceded them, since adverse events may also occur due to other reasons (for example a natural viral infection). OAE was created to represent the whole process from initial medical intervention to subsequent outcomes.
Description
More detailed information about this field from each metasource.
The Ontology of Adverse Events (OAE) is a community-driven ontology that is developed to standardize and integrate data on biomedical adverse events (e.g., vaccine and drug adverse events) and support computer-assisted reasoning. As a result of a medical intervention, events may occur which lie outside the intended consequences of the intervention. Some of these events are adverse events, in the sense that they are pathological bodily processes. For many such adverse events it is unclear whether they are causal consequences of the medical intervention which preceded them, since adverse events may also occur due to other reasons (for example a natural viral infection). OAE was created to represent the whole process from initial medical intervention to subsequent outcomes.
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
The Ontology of Adverse Events (OAE) is a community-based biomedical ontology in the domain of adverse events. OAE is developed to standardize adverse event annotation, integrate various adverse event data, and support computer-assisted reasoning. Its development follows the OBO Foundry principles.
metasource: Biontology / Bioportalversion: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
Webpage:
https://github.com/oae-ontologyWebpage
More detailed information about this field from each metasource.
https://github.com/oae-ontology
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
http://www.oae-ontology.org/
metasource: Biontology / Bioportalversion: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
Licence:
Name: Creative Commons Attribution 3.0 Unported (CC BY 3.0)Licence name
More detailed information about this field from each metasource.
Creative Commons Attribution 3.0 Unported (CC BY 3.0)
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
Licence URL
More detailed information about this field from each metasource.
https://creativecommons.org/licenses/by/3.0/
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
Publications:
Publications
More detailed information about this field from each metasource.
OAE: The Ontology of Adverse Events
PMID: 25093068
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
Publications
More detailed information about this field from each metasource.
OAE: The Ontology of Adverse Events
PMID: 25093068
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
metasource: Biontology / Bioportal
version: 1.2.47 extracted_at: 2022-11-04T11:10:15.597147, http://bioportal.bioontology.org/ontologies/OAE
-
OAE: The Ontology of Adverse Events
PubMed citations: 40.
40 articles citing: OAE: The Ontology of Adverse Events
Cov19VaxKB: A Web-based Integrative COVID-19 Vaccine Knowledge Base. PMID:34981039
TCDO: A Community-Based Ontology for Integrative Representation and Analysis of Traditional Chinese Drugs and Their Properties. PMID:34603473
Precision omics data integration and analysis with interoperable ontologies and their application for COVID-19 research. PMID:34159360
Pathway-Driven Coordinated Telehealth System for Management of Patients With Single or Multiple Chronic Diseases in China: System Development and Retrospective Study. PMID:33998999
A Minimal Information Model for Potential Drug-Drug Interactions. PMID:33762928
Towards semantic interoperability: finding and repairing hidden contradictions in biomedical ontologies. PMID:33319712
Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project. PMID:32939051
Ontological Organization and Bioinformatic Analysis of Adverse Drug Reactions From Package Inserts: Development and Usability Study. PMID:32706718
A 2018 workshop: vaccine and drug ontology studies (VDOS 2018). PMID:31865905
Machine learning-based identification and rule-based normalization of adverse drug reactions in drug labels. PMID:31865904
Ontological and Non-Ontological Resources for Associating Medical Dictionary for Regulatory Activities Terms to SNOMED Clinical Terms With Semantic Properties. PMID:31551780
Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches. PMID:31156424
ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions. PMID:31074377
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development. PMID:30532240
OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies. PMID:29997499
Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs. PMID:29880031
Ontology-Based Meta-Analysis of Animal and Human Adverse Events Associated With Licensed Brucellosis Vaccines. PMID:29867505
Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs. PMID:29854250
Where to search top-K biomedical ontologies? PMID:29579141
The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability. PMID:29329592
Ontology-based systematic representation and analysis of traditional Chinese drugs against rheumatism. PMID:29322929
Evaluating Casama: Contextualized semantic maps for summarization of lung cancer studies. PMID:29149658
Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China. PMID:29061976
Ontology-based specification, identification and analysis of perioperative risks. PMID:28877732
Analysis of Individual Differences in Vaccine Pharmacovigilance Using VAERS Data and MedDRA System Organ Classes: A Use Case Study With Trivalent Influenza Vaccine. PMID:28469434
Use of Biomedical Ontologies for Integration of Biological Knowledge for Learning and Prediction of Adverse Drug Reactions. PMID:28469412
The anatomy of phenotype ontologies: principles, properties and applications. PMID:28387809
Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request. PMID:28253937
Integrative representations and analyses of vaccine-induced intended protective immunity and unintended adverse events using ontology-based and theory-guided approaches. PMID:27868103
Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis. PMID:27749923
Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases. PMID:27694888
Community-based Ontology Development, Annotation and Discussion with MediaWiki extension Ontokiwi and Ontokiwi-based Ontobedia. PMID:27570653
Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research. PMID:27458549
Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events. PMID:27213033
Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors. PMID:27003817
Vaccine and Drug Ontology Studies (VDOS 2014). PMID:26918107
Perspectives on next steps in classification of oro-facial pain - part 2: role of psychosocial factors. PMID:26257252
eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment. PMID:25815161
The potential of translational bioinformatics approaches for pharmacology research. PMID:25753093
An effective method of large scale ontology matching. PMID:25411633
Tags:
Tags
More detailed information about this field from each metasource.
adverse reaction
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
drug
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
vaccine
metasource: Fairsharing.org
version: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
Tags
More detailed information about this field from each metasource.
adverse reaction
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
drug
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
vaccine
metasource: Fairsharing.orgversion: FAIRsharing.org: OAE; Ontology of Adverse Events; DOI: https://doi.org/10.25504/FAIRsharing.tw4q8x; Last edited: Dec. 16, 2019, 4:53 p.m.; Last accessed: Jan 03 2022 7:13 p.m.
Need help integrating and/or managing biomedical data?